Unraveling the Pathogenesis of Type 1 Diabetes with Proteomics: Present And Future Directions
Open Access
- 1 April 2005
- journal article
- review article
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 4 (4) , 441-457
- https://doi.org/10.1074/mcp.r500002-mcp200
Abstract
No abstract availableKeywords
This publication has 160 references indexed in Scilit:
- Current two‐dimensional electrophoresis technology for proteomicsProteomics, 2004
- Gene regulatory factors in pancreatic developmentDevelopmental Dynamics, 2003
- Modulation of gene expression by extracellular pH variations in human fibroblasts: A transcriptomic and proteomic studyProteomics, 2003
- Mass spectrometry-based proteomicsNature, 2003
- Global and societal implications of the diabetes epidemicNature, 2001
- IL-1β INDUCES SERINE PROTEASE INHIBITOR 3 (SPI-3) GENE EXPRESSION IN RAT PANCREATIC β-CELLS. DETECTION BY DIFFERENTIAL DISPLAY OF MESSENGER RNACytokine, 1999
- Endogenous nitric oxide induced by interleukin‐1β in rat islets of Langerhans and HIT‐T15 cells causes significant DNA damage as measured by the ‘comet’ assayFEBS Letters, 1993
- Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB ratsFEBS Letters, 1993
- Interleukin‐1 ‐induced expression of nitric oxide synthase in insulin‐producing cells is preceded by c‐fos induction and depends on gene transcription and protein synthesisFEBS Letters, 1993
- Insulin‐secreting β‐cells possess specific receptors for interleukin‐1βFEBS Letters, 1990